Distribution of 18F-5-Fluorouracil in tumor-bearing mice and rats
J. Shanij(University of Southern California), Kathleen F. Meaney(Arthur D. Little (United States)), D. Greenberg, Harold Atkins(University of Ottawa), R. MscGregor(Brookhaven National Laboratory), I Wodinsky(Arthur D. Little (United States)), Walter Wolf(University of Southern California), P.R. Bradley-Moore, V Casella(Brookhaven National Laboratory), T. Schlesinger(University of Southern California), P. Som(Brookhaven National Laboratory), Joanna S. Fowler(Brookhaven National Laboratory), T. Ido(Brookhaven National Laboratory), Richard M. Lambrecht, C. Mǎntescu(Brookhaven National Laboratory), A. P. Wolf(Brookhaven National Laboratory), R.D. Neirinckx(Brookhaven National Laboratory)
Cited by 34
Related Papers
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
|Cancer Cell|2003|850
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
|Nature Medicine|2000|816
A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18)
|Journal of Computer Assisted Tomography|1980|503
Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [ <sup>18</sup> F]Fluorodeoxyglucose and [ <sup>11</sup> C]Deoxyglucose
|Journal of Cerebral Blood Flow & Metabolism|1985|419